KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11 | 0.0% | 96 | 0.0% | 0.00% | – |
Q2 2023 | $11 | +37.5% | 96 | 0.0% | 0.00% | – |
Q1 2023 | $8 | 0.0% | 96 | 0.0% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 96 | 0.0% | 0.00% | – |
Q3 2022 | $7,000 | +16.7% | 96 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | +20.0% | 96 | +26.3% | 0.00% | – |
Q1 2022 | $5,000 | 0.0% | 76 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | +25.0% | 76 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | +33.3% | 76 | +76.7% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 43 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | +50.0% | 43 | +16.2% | 0.00% | – |
Q4 2020 | $2,000 | – | 37 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
Artal Group S.A. | 400,000 | $31,688 | 1.77% |
Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |